Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
Authors
Keywords
Osteoporosis, Teriparatide, Adherence, Persistence, Discontinuation, Medicare part D, Fractures, Outcomes
Journal
BMC MUSCULOSKELETAL DISORDERS
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-01-03
DOI
10.1186/1471-2474-14-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
- (2016) Oliver Bock Clinical Interventions in Aging
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
- (2012) Kurt A. Kennel et al. MAYO CLINIC PROCEEDINGS
- Out-of-Pocket Drug Costs and Drug Utilization Patterns of Postmenopausal Medicare Beneficiaries with Osteoporosis
- (2011) Leslie Jackson Conwell et al. American Journal Geriatric Pharmacotherapy
- The pathogenesis, diagnosis, investigation and management of osteoporosis
- (2011) S. K. Sandhu et al. JOURNAL OF CLINICAL PATHOLOGY
- The impact of teriparatide adherence and persistence on fracture outcomes
- (2011) S. Yu et al. OSTEOPOROSIS INTERNATIONAL
- Medicare Beneficiaries' Knowledge of and Choices Regarding Part D, 2005 to the Present
- (2010) Jennifer M. Polinski et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009
- (2010) S. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance
- (2010) S. A. Foster et al. OSTEOPOROSIS INTERNATIONAL
- Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold
- (2008) A. Cronk et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy
- (2008) I. Fogelman et al. CALCIFIED TISSUE INTERNATIONAL
- Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs
- (2008) John Hsu JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D
- (2008) Jeanne M. Madden JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users
- (2008) Jeffrey R Curtis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use
- (2008) James X. Zhang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Effects of Reaching the Drug Benefit Threshold on Medicare Membersʼ Healthcare Utilization during the First Year of Medicare Part D
- (2008) Marsha A. Raebel et al. MEDICAL CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More